These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23260686)
41. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M; BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203 [TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins. Regnath T; Mertes T; Ignatius R Euro Surveill; 2016 Sep; 21(36):. PubMed ID: 27632642 [TBL] [Abstract][Full Text] [Related]
43. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180 [TBL] [Abstract][Full Text] [Related]
44. Gonorrhea in Indonesia: High Prevalence of Asymptomatic Urogenital Gonorrhea but No Circulating Extended Spectrum Cephalosporins-Resistant Neisseria gonorrhoeae Strains in Jakarta, Yogyakarta, and Denpasar, Indonesia. Hananta IP; van Dam AP; Bruisten SM; Schim van der Loeff MF; Soebono H; de Vries HJ Sex Transm Dis; 2016 Oct; 43(10):608-16. PubMed ID: 27626188 [TBL] [Abstract][Full Text] [Related]
45. Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013. Cheng CW; Li LH; Su CY; Li SY; Yen MY J Microbiol Immunol Infect; 2016 Oct; 49(5):708-716. PubMed ID: 25442864 [TBL] [Abstract][Full Text] [Related]
47. Update on Treatment Options for Gonococcal Infections. Lancaster JW; Mahoney MV; Mandal S; Lawrence KR Pharmacotherapy; 2015 Sep; 35(9):856-68. PubMed ID: 26343813 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe. Cole MJ; Spiteri G; Town K; Unemo M; Hoffmann S; Chisholm SA; Amato-Gauci AJ; van de Laar M; Ison CA; Sex Transm Dis; 2014 Dec; 41(12):723-9. PubMed ID: 25581808 [TBL] [Abstract][Full Text] [Related]
49. Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary. Brunner A; Nemes-Nikodem E; Jeney C; Szabo D; Marschalko M; Karpati S; Ostorhazi E Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):53. PubMed ID: 27646968 [TBL] [Abstract][Full Text] [Related]
50. Keep an eye on Neisseria gonorrhoeae. Mehlen M; Saunier V; de Barbeyrac B; Gaboriau T; Bébéar C; Bercot B; Castor C; Levesque D; Cazanave C; Puges M Clin Microbiol Infect; 2020 Sep; 26(9):1183-1184. PubMed ID: 32156570 [No Abstract] [Full Text] [Related]
52. High Prevalence of Azithromycin-Resistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka, Japan. Tanaka M; Furuya R; Irie S; Kanayama A; Kobayashi I Sex Transm Dis; 2015 Jun; 42(6):337-41. PubMed ID: 25970312 [TBL] [Abstract][Full Text] [Related]
53. In vitro efficacy of 21 dual antimicrobial combinations comprising novel and currently recommended combinations for treatment of drug resistant gonorrhoea in future era. Singh V; Bala M; Bhargava A; Kakran M; Bhatnagar R PLoS One; 2018; 13(3):e0193678. PubMed ID: 29509792 [TBL] [Abstract][Full Text] [Related]
54. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269 [TBL] [Abstract][Full Text] [Related]
55. Antimicrobial susceptibility in Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914 [TBL] [Abstract][Full Text] [Related]
56. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015. Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519 [TBL] [Abstract][Full Text] [Related]
57. Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012. Bala M; Singh V; Bhargava A; Ramesh V Sex Transm Dis; 2015 Apr; 42(4):218-22. PubMed ID: 25763675 [TBL] [Abstract][Full Text] [Related]
58. Should we still use azithromycin for gonorrhoea treatment? Mensforth S; Ross JDC Sex Health; 2019 Sep; 16(5):442-448. PubMed ID: 31207203 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012. Yu RX; Yin Y; Dai XQ; Chen SC; Han Y; Zheng BJ; Zhang GY; Chen XS Sex Transm Dis; 2017 Apr; 44(4):197-201. PubMed ID: 28282644 [TBL] [Abstract][Full Text] [Related]
60. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. Allen VG; Mitterni L; Seah C; Rebbapragada A; Martin IE; Lee C; Siebert H; Towns L; Melano RG; Low DE JAMA; 2013 Jan; 309(2):163-70. PubMed ID: 23299608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]